Patents matching “dose”

WO 2026117667

DOSES DE TITRATION DE MARIDEBART CAFRAGLUTIDE

AMGEN INC [US] · Granted Jun 4, 2026 · Expires May 30, 2046

WO 2026107143

COMBINAISON DE DOSES FIXES D'ANTICORPS ANTI-FUCOSYL-GM1 ET D'ANTICORPS ANTI-PD-1 ET SES UTILISATIONS

BRISTOL MYERS SQUIBB CO [US] · Granted May 21, 2026 · Expires May 16, 2046

US 20260060930

New crystalline Forms, new pharmaceutical Composition and Dose Regimen of a Dipeptidyl peptidase I inhibitor for the Treatment of Patients with Bronchiectasis or other DPP-I mediated Diseases

BOEHRINGER INGELHEIM INT [DE] · Granted Mar 5, 2026 · Expires Feb 28, 2046

US 12410249

Low dose antibody-based methods for treating hematologic malignancies

Actinium Phamaceuticals, Inc. · Granted Sep 9, 2025 · Expires Sep 4, 2045

US 12404337

Compositions, doses, and methods for treatment of thyroid eye disease

Viridian Therapeutics, Inc. · Granted Sep 2, 2025 · Expires Aug 28, 2045

US 12290596

Compositions and methods for the treatment of opioid overdose

Indivior UK Limited · Granted May 6, 2025 · Expires May 1, 2045

US 12214218

Perfusion modulated tumor dose sculpting with single dose radiotherapy

FUNDAçÃO D. ANNA DE SOMMER CHAMPALIMAUD E DR. CARLOS MONTEZ CHAMPALIMAUD · Granted Feb 4, 2025 · Expires Jan 30, 2045

US 12208093

Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)

THE UNITED STATES OF AMERICA, represented by the Secretary, Department of Health and Human Services · Granted Jan 28, 2025 · Expires Jan 23, 2045

US 12168036

Methods for treating angiogenic eye disorders with high doses of VEGF receptor fusion proteins

REGENERON PHARMACEUTICALS, INC. · Granted Dec 17, 2024 · Expires Dec 12, 2044

US 11931463

All-in-one fixed-dose combination for treating Helicobacter pylori infection

RedHill Biopharma Ltd. · Granted Mar 19, 2024 · Expires Mar 14, 2044

US 2023302008

METHODS OF ADMINISTERING INTRAVENOUS MELOXICAM IN A BOLUS DOSE

ALKERMES PHARMA IRELAND LTD [IE] · Granted Sep 28, 2023 · Expires Sep 23, 2043

US 11744816

Fixed dose combinations and formulations comprising ETC1002 and ezetimibe and methods of treating or reducing the risk of cardiovascular disease

Esperion Therapeutics, Inc. · Granted Sep 5, 2023 · Expires Aug 31, 2043

US 11590154

Triple antibiotic fixed-dose combination products, dosing regimen, methods, and kits for treating pulmonary non-tuberculosis mycobacterial infections

RedHill Biopharma Ltd. · Granted Feb 28, 2023 · Expires Feb 23, 2043

US 11590221

Dengue vaccine unit dose and administration thereof

Takeda Vaccines, Inc. · Granted Feb 28, 2023 · Expires Feb 23, 2043

US 11547663

Unit aerosol doses for anticoagulation

The Regents of the University of California · Granted Jan 10, 2023 · Expires Jan 5, 2043

US 11464815

Dengue vaccine unit dose and administration thereof

Takeda Vaccines, Inc. · Granted Oct 11, 2022 · Expires Oct 6, 2042

US 11400063

Early administration of low-dose colchicine after myocardial infarction

INSTITUT DE CARDIOLOGIE DE MONTREAL · Granted Aug 2, 2022 · Expires Jul 28, 2042

US 11351120

Use of higher doses of modified release huperzine formulations

Supernus Pharmaceuticals, Inc. · Granted Jun 7, 2022 · Expires Jun 2, 2042

US 11292835

Low dose antibody-based methods for treating hematologic malignancies

Actinium Phamaceuticals, Inc. · Granted Apr 5, 2022 · Expires Mar 31, 2042

US 11260185

Pressurized metered dose inhalers and method of manufacture

Cardiff Scintigraphics Limited · Granted Mar 1, 2022 · Expires Feb 24, 2042

US 11253511

Use of low dose emetine for inhibition of human cytomegalovirus (HCMV)

THE UNITED STATES OF AMERICA, as represented by th · Granted Feb 22, 2022 · Expires Feb 17, 2042

US 11207270

Controlled release dosage forms for high dose, water soluble and hygroscopic drug substances

Jazz Pharmaceuticals, Inc. · Granted Dec 28, 2021 · Expires Dec 23, 2041

US 11197928

Sustained production of high affinity antigen specific antibody by high dose BAFF receptor-targeting mAb-siRNA conjugate

The Board of Regents of the University of Texas System · Granted Dec 14, 2021 · Expires Dec 9, 2041

US 11141404

Formulations and methods for treating acute cannabinoid overdose

Anebulo Pharmaceuticals, Inc. · Granted Oct 12, 2021 · Expires Oct 7, 2041